|Articles|October 14, 2022
- Applied Clinical Trials-10-01-2022
- Volume 31
- Issue 10
Applied Clinical Trials October 2022 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials October 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 3 years ago
Managing Biospecimens in Cell and Gene Therapy Trialsover 3 years ago
The Risk-Reward Proposition for CGT Clinical Trialsover 3 years ago
Philadelphia Shines in Cell and Gene Therapy Research Pursuitsover 3 years ago
Survey Investigates Backup Solution Adoption for ePRO Systemsover 3 years ago
Scientists Don’t Ever Stop Sciencingover 3 years ago
Key Clinical Trial Industry Themes Post-COVIDNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
5
